Health

UK Researchers Develop Blood Test For Real-Time Lung Cancer Detection

A team of UK researchers has developed an innovative blood test that can detect and monitor lung cancer in real time, potentially reducing diagnostic delays and improving patient outcomes.

Using Fourier Transform Infrared (FT-IR) microspectroscopy, the researchers successfully identified a single lung cancer cell in a patient’s blood.

The technique combines advanced infrared scanning with computer analysis, focusing on the unique chemical ‘fingerprint’ of cancer cells.

Professor Josep Sulé-Suso, Associate Specialist in Oncology at University Hospitals of North Midlands NHS Trust (UHNM) and lead author, explained that the method could allow patients to receive earlier diagnoses, more personalised treatments, and fewer invasive procedures.

He further added that the approach could eventually be applied to other types of cancer beyond lung cancer.

Circulating tumour cells (CTCs) are cancer cells that detach from tumours and travel through the bloodstream. They provide crucial insights into disease progression and treatment response and are responsible for metastases.

Existing methods for detecting CTCs are often complex, costly, and time-consuming, and can sometimes fail to identify cancer cells as they change characteristics in circulation.

The researchers’ method shines an infrared beam onto a blood sample. Similar to a TV remote control but far more powerful, this beam interacts with chemicals in the blood. CTCs absorb the infrared light differently, creating a unique chemical fingerprint.

Computer algorithms then analyse the data to determine the presence of tumour cells.

Simpler and More Affordable Approach

The technique, published in Applied Spectroscopy, is simpler and more affordable than current approaches. It uses standard glass slides found in pathology labs, making it easier to integrate into routine clinical practice.

The research team plans to test the method in larger patient groups, aiming to develop a rapid, automated blood test that could become part of standard cancer care pathways.

If widely adopted, this innovation could transform lung cancer diagnosis and monitoring, providing clinicians with real-time insights and potentially improving survival rates for patients worldwide.

Also Read: US Longevity Specialist Separates ‘Healthy’ Hype From Nutritional Reality

Geetanjali Mishra

Recent Posts

Adani Energy Solutions Secures ₹500-Crore Bihar Power Transmission Project

Adani Energy Solutions has secured a Bihar transmission project to evacuate 2,400 MW of power…

17 mins ago

Portrait Of Former BHU Chancellor Kashi Naresh Dr Vibhuti Narayan Singh Unveiled At Malaviya Bhavan

BHU unveiled a portrait of former Chancellor and Kashi Naresh Dr Vibhuti Narayan Singh at…

3 hours ago

Sensex Jumps 898 Points; Nifty Closes Above 25,800 As Banking Stocks Lead Rally

Sensex and Nifty rallied for a second session as banking stocks gained on expectations of…

3 hours ago

PM Modi Highlights Role Of Indigenous Vaccines In Protecting Farmers’ Livestock

PM Modi highlighted indigenous vaccines' role in protecting livestock, reducing disease losses and strengthening farmers'…

4 hours ago

PM Modi Shares Sanskrit Shloka From Skanda Purana; Highlights Respect For Parents

PM Modi shared a Sanskrit verse from Skanda Purana, highlighting truth, purity, dharma and the…

5 hours ago

CM Yogi Adityanath’s Mother Savitri Devi Passes Away At 91 In Uttarakhand

Uttar Pradesh Chief Minister Yogi Adityanath’s mother, Savitri Devi, passed away at 91 at her…

7 hours ago